Training future doctors to understand and treat immune system disorders
Physician Scientist Training Program in Immune Dysregulation
['FUNDING_TRAINING'] · UNIVERSITY OF PENNSYLVANIA · NIH-10769362
This program is designed to help doctors and researchers learn how to better understand and treat immune system disorders that can cause serious health problems for both adults and kids.
Quick facts
| Phase | ['FUNDING_TRAINING'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PENNSYLVANIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-10769362 on ClinicalTrials.gov |
What this research studies
This program trains physician-scientists to explore the causes of immune dysregulation syndromes, which can lead to serious health issues. Participants will learn how to diagnose, monitor, and develop new treatments for these conditions. The training combines both adult and pediatric immune disease research, leveraging resources from the University of Pennsylvania and the Children's Hospital of Philadelphia. The program emphasizes a multidisciplinary approach, integrating basic and translational research in immunobiology.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with immune system disorders or those interested in the latest advancements in immunology.
Not a fit: Patients with conditions unrelated to immune dysregulation may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment options for patients suffering from immune dysregulation syndromes.
How similar studies have performed: Previous research in similar training programs has shown success in advancing the understanding and treatment of immune-related conditions.
Where this research is happening
PHILADELPHIA, UNITED STATES
- UNIVERSITY OF PENNSYLVANIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KAMBAYASHI, TAKU — UNIVERSITY OF PENNSYLVANIA
- Study coordinator: KAMBAYASHI, TAKU
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.